Sam Backenroth
2015 - Ohr Pharmaceutical
In 2015, Sam Backenroth earned a total compensation of $664.6K as Chief Financial Officer at Ohr Pharmaceutical, a 44% decrease compared to previous year.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Option Awards | $296,746 |
| Salary | $200,000 |
| Other | $17,877 |
| Total | $664,623 |
Backenroth received $296.7K in option awards, accounting for 45% of the total pay in 2015.
Backenroth also received $150K in bonus, $200K in salary and $17.9K in other compensation.
Rankings
In 2015, Sam Backenroth's compensation ranked 9,733rd out of 13,638 executives tracked by ExecPay. In other words, Backenroth earned more than 28.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,733 out of 13,638 | 29th |
Division Manufacturing | 3,714 out of 5,190 | 28th |
Major group Chemicals And Allied Products | 1,357 out of 1,854 | 27th |
Industry group Drugs | 1,111 out of 1,528 | 27th |
Industry Pharmaceutical Preparations | 871 out of 1,182 | 26th |
Source: SEC filing on March 3, 2017.
Backenroth's colleagues
We found two more compensation records of executives who worked with Sam Backenroth at Ohr Pharmaceutical in 2015.